Qiuyi Huang

Shanghai, 200032, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

TGF-β1-induced RAP2 regulates invasion in pancreatic cancer.

TGF-β1-induced RAP2 regulates invasion in pancreatic cancer.

Journal: Acta biochimica et biophysica Sinica

Published: May 10, 2022

Partial omentectomy maybe practicable for T3 or shallower gastric cancer patients.

Partial omentectomy maybe practicable for T3 or shallower gastric cancer patients.

Journal: Cancer medicine

Published: December 13, 2021

Novel Nomograms-Based Prediction Models for Patients with Primary Undifferentiated Pleomorphic Sarcomas Resections.

Novel Nomograms-Based Prediction Models for Patients with Primary Undifferentiated Pleomorphic Sarcomas Resections.

Journal: Cancers

Published: February 24, 2021

Fibrinogen/Albumin Ratio as a Promising Marker for Predicting Survival in Pancreatic Neuroendocrine Neoplasms.

Fibrinogen/Albumin Ratio as a Promising Marker for Predicting Survival in Pancreatic Neuroendocrine Neoplasms.

Journal: Cancer management and research

Published: August 03, 2020

Roles of CA19-9 in pancreatic cancer: Biomarker, predictor and promoter.

Roles of CA19-9 in pancreatic cancer: Biomarker, predictor and promoter.

Journal: Biochimica et biophysica acta. Reviews on cancer

Published: June 01, 2020

High pre-operative fasting blood glucose levels predict a poor prognosis in patients with pancreatic neuroendocrine tumour.

High pre-operative fasting blood glucose levels predict a poor prognosis in patients with pancreatic neuroendocrine tumour.

Journal: Endocrine

Published: May 07, 2020

Absolute Counts of Peripheral Lymphocyte Subsets Correlate with the Progression-Free Survival and Metastatic Status of Pancreatic Neuroendocrine Tumour Patients.

Absolute Counts of Peripheral Lymphocyte Subsets Correlate with the Progression-Free Survival and Metastatic Status of Pancreatic Neuroendocrine Tumour Patients.

Journal: Cancer management and research

Published: April 21, 2020

Resected Pancreatic Cancer With N2 Node Involvement Is Refractory to Gemcitabine-Based Adjuvant Chemotherapy.

Resected Pancreatic Cancer With N2 Node Involvement Is Refractory to Gemcitabine-Based Adjuvant Chemotherapy.

Journal: Cancer control : journal of the Moffitt Cancer Center

Published: April 10, 2020

Prognosis of distal pancreatic cancers controlled by stage.

Prognosis of distal pancreatic cancers controlled by stage.

Journal: Experimental and therapeutic medicine

Published: March 23, 2020

Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma.

Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma.

Journal: Journal of hematology & oncology

Published: March 11, 2020

Lewis antigen‑negative pancreatic cancer: An aggressive subgroup.

Lewis antigen‑negative pancreatic cancer: An aggressive subgroup.

Journal: International journal of oncology

Published: December 26, 2019

Kras mutation correlating with circulating regulatory T cells predicts the prognosis of advanced pancreatic cancer patients.

Kras mutation correlating with circulating regulatory T cells predicts the prognosis of advanced pancreatic cancer patients.

Journal: Cancer medicine

Published: November 21, 2019

Showing 1-12 of 25

Last Updated: 09/26/2026